The Spectranetics Corporation

SPNC develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are sold in numerous countries and are used to treat arterial blockages in the heart and legs and in the removal of pacemaker and defibrillator leads. The Company’s Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee, the AngioSculpt scoring balloon used in both peripheral and coronary procedures and Stellarex drug-coated balloon peripheral angioplasty platform. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and cardiac laser catheters to treat blockages in the heart. The Lead Management (LM) product line includes excimer laser sheaths, dilator sheaths, mechanical sheaths and accessories for the removal of pacemaker and defibrillator cardiac leads.
Colorado Springs, US
Size (employees)
960 (est)+8%
The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, US

The Spectranetics Corporation Office Locations

The Spectranetics Corporation has an office in Colorado Springs
Colorado Springs, US (HQ)
9965 Federal Dr

The Spectranetics Corporation Data and Metrics

The Spectranetics Corporation Financial Metrics

The Spectranetics Corporation's revenue was reported to be $270.8 m in FY, 2016 which is a 10% increase from the previous period.

Revenue (FY, 2016)

270.8 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

202.5 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(58.1 m)

EBIT (FY, 2016)

(43.6 m)

Market capitalization (26-Jun-2017)

1.3 b

Closing share price (26-Jun-2017)


Cash (31-Dec-2016)

57.2 m
The Spectranetics Corporation's current market capitalization is $1.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


158.8 m204.9 m246 m270.8 m

Revenue growth, %


Cost of goods sold

41.4 m51.4 m62.9 m68.3 m

Gross profit

117.5 m153.5 m183.1 m202.5 m

Gross profit Margin, %


Operating expense total

117.1 m188.4 m233.4 m246.1 m


394 k(37 m)(50.5 m)(43.6 m)

EBIT margin, %


Interest expense

13.3 m

Pre tax profit

410 k(41.2 m)(58.7 m)(57.3 m)

Income tax expense

780 k(322 k)726 k787 k

Net Income

(370 k)(40.9 m)(59.5 m)(58.1 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016


128.4 m95.5 m84.6 m57.2 m


2.7 m8.1 m8.1 m7.1 m

Current Assets

167.8 m172.3 m158.3 m135.5 m


28.3 m33.8 m44.7 m44.8 m


14.8 m149.9 m152.6 m148.8 m

Total Assets

217.2 m467 m468 m430.1 m

Accounts Payable

2.6 m4.4 m4.4 m6.2 m

Current Liabilities

23.2 m41.3 m63.7 m66.9 m

Additional Paid-in Capital

284.5 m298.5 m313.4 m332.7 m

Retained Earnings

(94.2 m)(135.1 m)(194.6 m)(252.7 m)

Total Equity

117 m74.3 m

Financial Leverage

4 x5.8 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(370 k)(40.9 m)(59.5 m)(58.1 m)

Depreciation and Amortization

10.6 m16.8 m26.6 m27.4 m

Accounts Receivable

(2.7 m)(2.7 m)(398 k)


(359 k)497 k497 k(3.7 m)

Cash From Operating Activities

4.2 m(20.4 m)(59.5 m)

Capital Expenditures

(4.6 m)(6.7 m)(9.5 m)(5.4 m)

Cash From Investing Activities

(11.1 m)(240.7 m)(39.5 m)(5.4 m)

Cash From Financing Activities

97.3 m228.2 m88.2 m2.4 m

Interest Paid

41 k3 m6.5 m12.1 m

Income Taxes Paid

357 k787 k327 k445 k

Free Cash Flow

8.8 m(13.7 m)(49.9 m)
USDY, 2016


303.6 k

Financial Leverage

5.8 x

The Spectranetics Corporation Market Value History

The Spectranetics Corporation Company Life and Culture

You may also be interested in